Skip to content
Wednesday, September 27, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • PAST MAGAZINE ISSUES
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • FEATURES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Alameda Healthcare Group strikes new 7-year pact with Siemens Healthineers
  • Egypt earns digital health recognition at Arab Hospitals Federation’s annual awards
  • Medshield Medical Scheme unveils a vision for 2024 to deliver quality healthcare across all life stages
  • Nairobi Hospital makes pioneering commitment to global sustainability and healthcare innovation
  • GHLF and Darna Center join hands to enhance healthcare equity for African women
  • Amanat names Dr. Howard Podolsky as the new Group CEO of Cambridge Medical & Rehabilitation Center
  • Applications open for the prestigious Aster Guardians Global Nursing Award 2024
  • Gates Foundation fuels GE HealthCare's AI-driven healthcare revolution with US$44 million boost
  • M-PESA Foundation constructs KES 16 million maternal health complex for Kisumu County
  • Alkem Laboratories inks antifungal drug deal with Biosergen
You are here
  • Home
  • Johnson & Johnson

Tag: Johnson & Johnson

Johnson & Johnson faces investigation for allegedly overpricing critical tuberculosis drug in South Africa

19 September 202319 September 2023

SOUTH AFRICA —Pharmaceutical giant Johnson & Johnson (J&J), headquartered in the United States, is now under scrutiny in South Africa for purportedly imposing “excessive” pricing on a vital tuberculosis medication,…

Read More

South Africa’s COVID-19 vaccine contracts reveal disparities and risk assumptions

7 September 20237 September 2023

SOUTH AFRICA — An analysis of South Africa’s COVID-19 vaccine contracts has shed light on pricing disparities and risk assumptions made by pharmaceutical companies. According to the Health Justice Initiative…

Read More

Neuromedicine startup Rapport Therapeutics secures US$150 million in Series B funding to propel clinical progress

24 August 202325 August 2023

USA — Rapport Therapeutics, a cutting-edge neuromedicine startup backed by Johnson & Johnson, has announced the successful completion of a remarkable US$150 million series B funding round. Having launched earlier…

Read More

Biosense Webster’s FDA approval paves the way for zero fluoroscopy workflow

14 August 202314 August 2023

USA —Biosense Webster, a distinguished entity within Johnson & Johnson MedTech has unveiled its triumphant achievement of gaining U.S. Food and Drug Administration (FDA) approval for a zero-fluoroscopy workflow for…

Read More

FDA greenlights Johnson & Johnson’s Akeega for BRCA-positive prostate cancer

14 August 202314 August 2023

USA — Johnson & Johnson has secured the coveted FDA approval for Akeega, a pioneering combination tablet poised to redefine the landscape of metastatic castration-resistant prostate cancer (mCRPC) treatment in…

Read More

Johnson & Johnson names the new Managing Director of its medical device business in India

27 July 202327 July 2023

INDIA – Johnson & Johnson Private Limited has selected Anuj Virmani as the new Managing Director for its medical device business in India. Anuj Virmani has been tapped as the…

Read More

Johnson & Johnson foresees robust growth in 2023, bolstered by medical advancements and pharmaceutical portfolio

21 July 202321 July 2023

USA —Johnson & Johnson, a prominent healthcare conglomerate, is brimming with optimism as it anticipates a year of strong growth, surpassing profit estimates. The resurgence of joint replacement surgeries and…

Read More

Johnson & Johnson fights back to challenge the prescription price battle, claiming constitutional violations

20 July 202320 July 2023

USA — As the battle intensifies over a new law aimed at lowering prescription drug prices, Johnson & Johnson’s pharmaceutical unit, Janssen Pharmaceuticals, has entered the fray, arguing that the…

Read More

Doctors Without Borders Criticizes Johnson & Johnson’s TB drug agreement

19 July 202319 July 2023

SWITZERLAND —Efforts to expand access to Johnson & Johnson’s tuberculosis (TB) drug, Sir­turo (bedaquiline), have faced criticism from Médecins Sans Frontières (MSF), also known as Doctors Without Borders. The deal…

Read More

TB drug agreement fails to address high-burden countries in Eastern Europe and Central Asia, raising concerns

17 July 202317 July 2023

SWITZERLAND —A recent licensing agreement between pharmaceutical giant Johnson & Johnson (J&J) and the Stop TB Partnership has sparked debate over its effectiveness in expanding access to life-saving tuberculosis (TB)…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

UPCOMING EVENTS

Africa Health Expo

March 7-9, 2024

Visa Oshwal Centre, Nairobi, Kenya

Africa Hospitals & Wellness Expo

March 7-9, 2024

Visa Oshwal Centre, Nairobi, Kenya

LATEST NEWS

  • Alameda Healthcare Group strikes new 7-year pact with Siemens Healthineers
  • Egypt earns digital health recognition at Arab Hospitals Federation’s annual awards
  • Medshield Medical Scheme unveils a vision for 2024 to deliver quality healthcare across all life stages
  • Nairobi Hospital makes pioneering commitment to global sustainability and healthcare innovation
  • GHLF and Darna Center join hands to enhance healthcare equity for African women

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Johnson & Johnson Kenya Malaria Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Partnerships Pfizer Pharmaceuticals Public Health Roche Rwanda Saudi Arabia Science & Technology South Africa Switzerland Tanzania technology UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

QUICK LINKS

Advertise 

Contact the Publisher

About the Magazine

Press Releases

Subscribe to E-Newsletter

RELATED PUBLICATIONS

Food Business Africa

Food Safety Africa

Milling Middle East & Africa

Sustainable Packaging Africa

CEO Business Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.